Integron and Samsung to Demonstrate Digital Health Innovation at HIMSS18

  • February 19, 2018


Integron and Samsung Healthcare are teaming up at HIMSS18 to demonstrate digital health solutions which are transforming the health and wellness industry for physicians, nurses, and patients.

Integron will be joining Samsung Healthcare to discuss how digital health innovations are transforming healthcare. Take a break from the expo floor and join us in Room #606 (Level 1) for an exclusive hands-on experience of our latest Healthcare Solutions. Integron's comprehensive set of managed services provide value to the connected health, clinical drug trial, telehealth and remote patient monitoring sectors of the healthcare industry.

Integron will be showcasing our capabilities in clinical trial support, demonstrating how we are helping leading pharma and life sciences companies utilize connected healthcare devices and wearable technology from Samsung to make the capture of patient data more efficient and cost-effective, improving the patient experience, resulting in reduced time to bring new research treatments to market.

At Integron, we are partering with Samsung Healthcare and working together with several leading healthcare and pharmaceutical companies to streamline the process of sourcing, provisioning, validating, securing, and connecting mobile devices that are being used for patient data collection within clinical trials across the globe. Our managed services include an implementation of Mobile Device Management (MDM), specifically tailored to the unique patient privacy and security requirements for the healthcare industry. Wrapped around these services is our Project Management and Consulting, which provide oversight and guidance for our enterprise customers looking to navigate the complexities of the IoT and connected clinical trials. For our customers, the results include lower risk, reduced costs, and improved efficiency in the operation and execution of clinical trials.

To support this effort, we've grown our partner ecosystem to include several leading companies throughout the clinical trial value chain. Earlier this year, we announced a partnership with Stefanini, a global IT outsourcing firm, Clinical Ink, an ePRO and patient engagement software provider, and have also demonstrated success with supporting connected clinical trials with mProve and Samsung Healthcare.

With over 40 clinical trials being supported by Integron across the globe, our managed connectivity and device provisioning services are being leveraged to provide a range of benefits for our customers:

  • More accurate and continuous monitoring that will lead to better data - Use of mobile devices, wearables, and IoT technology can reduce errors associated with human data collection and provide medical-grade biometrics
  • Improved Patient recruitment and retention - Remote patient monitoring and use of ePRO/eDiary software, delivered through mobile devices, improves patient experience
  • Enhanced patient experience - IoT technology and smart devices will provide patients with constant insight into their health, making them feel more at ease when entering into early phase clinical trials


We look forward to seeing you at HIMSS18 in Las Vegas!